Aktiesnakken — Juni 2010
-
nu bliver det da vildt vildt spændende i morgen
-
og analytikerne har ihvertfald fået deres vilje
-
jeg synes bare genmab virker enorm stærk
-
jeg tror van der vinkel forhandler salg af genmab til gsk
-
200 er nok lidt for spændende
-
Det lader til at Lisa og Winkel inviterede analytikere til frokost sent i går eftermiddag - og tidligt i dag bliver hun fyret
-
eller også tager hun sit tøj og går. Der er sket et eller andet
dramatisk siden i går
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind